Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

NCT00367913 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Diseases

Interventions

DRUG: Addition of clarithromycin to rifampicin and ethambutol
DRUG: Addition of Ciprofloxacin to rifampicin and ethambutol
BIOLOGICAL: Vaccination with M.vaccae

Sponsor

British Thoracic Society